Drug
AG 270
AG 270: highest development phase Phase 1, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| AG-270 NCT03435250 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow AG 270 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.